Dougherty & Co Upgrades IPC The Hospitalist Company (IPCM) to Buy
Get Alerts IPCM Hot Sheet
Price: $80.17 --0%
Rating Summary:
0 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
0 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Dougherty & Co.'s Brooks O'Neil and Deepak Chaulagai upgraded shares of IPC The Hospitalist Company (NASDAQ: IPCM) from Neutral to Buy following Tuesday afternoon's Q4 results and FY12 guidance. The firm's price target was raised from $41 to $45.
The analysts said, "In our mind, the key point is it looks like the worst is behind IPCM."
With IPC shares up 7 percent to $37.45 at last check, Dougherty's new price target represents potential upside of about 20 percent.
For an analyst ratings summary and ratings history on IPC The Hospitalist Company click here. For more ratings news on IPC The Hospitalist Company click here.
The analysts said, "In our mind, the key point is it looks like the worst is behind IPCM."
With IPC shares up 7 percent to $37.45 at last check, Dougherty's new price target represents potential upside of about 20 percent.
For an analyst ratings summary and ratings history on IPC The Hospitalist Company click here. For more ratings news on IPC The Hospitalist Company click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- UBS says bull market has further to run
- Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group
Create E-mail Alert Related Categories
UpgradesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share